Mutual funds pump in Rs 6,500-cr in stocks in Apr-May

By: |
New Delhi | Updated: Jun 05, 2016 4:27 PM

Mutual fund managers have pumped in more than Rs 6,500 crore into equities in the first two months of the current fiscal amid sustained volatility in the stock markets.

MFs are investment vehicles made up of a pool of funds collected from a large number of investors and invest in stocks, bonds and money market instruments, among others. (Reuters)

Mutual fund managers have pumped in more than Rs 6,500 crore into equities in the first two months of the current fiscal amid sustained volatility in the stock markets.

This comes on the top of more than Rs 64,000 crore invested in the entire past fiscal.

Growing participation from retail investors, especially from small towns, and several measures taken by markets regulator Sebi led to robust inflows in equities, industry experts said.

The regulator has given extra incentives for those expanding into smaller cities.

Equities witnessed a net outflow of Rs 575 crore in April, while a net inflow of Rs 7,149 crore was seen in May, resulting into a net inflow of Rs 6,573 crore according to latest data with markets regulator Sebi.

Smaller towns have contributed more than 40 per cent of inflows in equity schemes.

“Domestic mutual funds have been bullish on the equities ever since the Narendra Modi-led BJP government came to power at the Centre in May 2014,” Quantum AMC Director I V Subramaniam said.

Meanwhile, the 30-share benchmark index Sensex has risen over five per cent in the first two months (April-May) of the ongoing financial year.

MFs are investment vehicles made up of a pool of funds collected from a large number of investors and invest in stocks, bonds and money market instruments, among others.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Analyst Corner: MRF rating ‘sell’ – Results were better than estimated
2Analyst Corner: ONGC rating ‘buy’ – Impairment loss hit the bottomline
3Analyst Corner: Glenmark Pharma Rating ‘hold’ – A healthy performance in the quarter